ArticleJournal of inherited metabolic disease2026

Shifting Towards Empagliflozin First-Line Therapy in Glycogen Storage Disease Type Ib: A Nationwide Real-World Study.

Sema Kalkan Uçar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.